Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Samyang Corporation

Latest From Samyang Corporation

Abingworth Offers Home For Big Pharma Pipeline Projects

The UK-headquartered life sciences investment firm has comfortably exceeded its target of $350m for a fund dedicated to taking on late-stage products, incurring all the clinical and regulatory risk and receiving a pre-negotiated return once the drug is approved.

Financing Clinical Trials

Finance Watch: SPAC Spree To Continue ‘For Foreseeable Future’

Public Company Edition: Merging with a special purpose acquisition corporation may be an attractive alternative to an initial public offering, but February’s vigorous IPO pace includes seven recent offerings that raised $480.8m in the US. Also, Cassava raised $200m and KalVista brought in $222.5m.

Financing Deals

Abingworth Raises $465m To Back And Build New Biotechs

The ABV 8 fund will invest $15m to $30m per company across the range from start-ups to development-stage companies.

Financing StartUps and SMEs

Finance Watch: Inhibikase IPO Brought 2020 US Total To 86

Public Company Edition: The new year started with two companies signaling plans for significant near-term initial public offerings, following Inhibikase’s launch as the last IPO of 2020. Other recent financial highlights include layoffs at Calithera and Regenxbio’s $200m Zolgensma royalty sale.

Financing Business Strategies
See All

Company Information

  • Industry
  • Diversified
  • Contract Manufacturing Organization
  • Other Names / Subsidiaries
    • Samyang Pharmaceuticals Corp.
    • Samyang Biopharm USA, Inc.
UsernamePublicRestriction

Register